Perspectives
Perspectives
Ideas, developments and experiences shaping healthcare and life sciences in the UAE, the wider GCC and internationally.
Here we share our perspectives on science, investment, policy, innovation and market development, alongside news from ManaraMED and selected outcomes from our work with clients and partners.
Browse by theme
Perspectives · Data Governance
September 21, 2026
Data governance is becoming an investment issue
For data-intensive healthcare and life-sciences companies, privacy is no longer simply a compliance question. The ability to legitimately use, scale and commercialise data can increasingly affect the investment case itself.
Read the article
Firm News · United States
August 31, 2026
ManaraMED establishes a presence in the United States
ManaraMED has established ManaraMED LLC in the United States, strengthening the firm’s ability to work with US healthcare and life-sciences companies pursuing opportunities in the Gulf Cooperation Council.
Read the announcement
Clinical Research Roundtables · UAE
June 18, 2026
A Reflection on #CRR2 by Marwan Abdulaziz Janahi
SVP of Dubai Science Park reflects on the second Clinical Research Roundtable: change becomes possible when better outcomes are clear and the right stakeholders act together. The discussion brought clinicians, hospital groups, biotech companies, legal experts, government voices and academia together around practical, implementable steps for the UAE to become home to global clinical trials.
Read the reflection on CRR-UAE
Clinical Research Roundtables · UAE
June 11, 2026
CRR #2 recap: building the national layer of UAE clinical research
The second UAE Clinical Research Roundtable brought senior decision-makers from government, healthcare providers, academia and industry together to work through what a national layer for clinical research in the UAE requires — from coordinated approvals and site readiness to data infrastructure and sponsor confidence. ManaraMED works closely with the Roundtables and contributes to this agenda.
Read the recap on CRR-UAE
Capital & Strategy
February 8, 2026
The invisible segment: why smaller family offices remain underallocated to venture and growth opportunities
Smaller family offices control meaningful capital but remain underallocated to venture and growth opportunities. The constraint is rarely a lack of capital; it is the absence of curated, structured opportunities that match their investment logic and internal capacity. This piece examines the gap between deal flow and usable opportunities, and why trust and specialised translation matter — especially in healthcare and life sciences.
Read the essayRelated initiatives
ManaraMED works closely with two platforms that help explain the research and clinical landscape in the UAE and wider GCC. Visitors may find them useful for context.
Discover active trials in the UAE, self-refer, enquire, refer a patient — all in one pulse.
UAE TrialPulseThe UAE Clinical Research Roundtables bring senior decision-makers together four times a year to advance the country's clinical research ecosystem — one focused theme at a time. They are designed to support the ecosystem broadly, including government priorities, not only industry needs.
Clinical Research Roundtables UAE